Baker Brothers Advisors - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$710,000
+10.8%
147,9960.0%0.00%
+50.0%
Q4 2020$641,000
-5.0%
147,996
-9.7%
0.00%
-33.3%
Q3 2020$675,000
+52.7%
163,830
-5.1%
0.00%
+50.0%
Q2 2020$442,000
-11.4%
172,6300.0%0.00%
-33.3%
Q1 2020$499,000
-23.7%
172,6300.0%0.00%0.0%
Q4 2019$654,000
-25.9%
172,6300.0%0.00%
-50.0%
Q3 2019$883,000
-17.5%
172,6300.0%0.01%
-14.3%
Q2 2019$1,070,000
-12.8%
172,6300.0%0.01%
-12.5%
Q1 2019$1,227,000
-16.8%
172,6300.0%0.01%
-33.3%
Q4 2018$1,474,000
-57.3%
172,6300.0%0.01%
-47.8%
Q3 2018$3,456,000
-22.5%
172,6300.0%0.02%
-32.4%
Q2 2018$4,459,000
+8.1%
172,6300.0%0.03%
-2.9%
Q1 2018$4,126,000
-29.5%
172,6300.0%0.04%
-31.4%
Q4 2017$5,850,000
+60.1%
172,6300.0%0.05%
+70.0%
Q3 2017$3,655,000
+21.1%
172,6300.0%0.03%
+15.4%
Q2 2017$3,019,000
-0.1%
172,6300.0%0.03%
+4.0%
Q1 2017$3,021,000
+3.6%
172,6300.0%0.02%
-13.8%
Q4 2016$2,917,000
+3.0%
172,6300.0%0.03%
+11.5%
Q3 2016$2,833,000
+8.4%
172,6300.0%0.03%
-3.7%
Q2 2016$2,614,000
+4.7%
172,6300.0%0.03%
+3.8%
Q1 2016$2,496,000172,6300.03%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders